Topiramate Tablet, Film Coated
Product Images NDC 70518-1718

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-1718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 01)

Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 01)
Chemical structure of topiramate, showing its molecular arrangement with various functional groups including sulfonamide and several oxygen-containing rings.*
FDA Label Image

Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 02)

Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 02)
A line graph showing cumulative rates for time to first seizure over 500 days comparing Topiramate 50 mg/day (solid line) and Topiramate 400 mg/day (dashed line). The vertical axis represents cumulative rates, while the horizontal axis shows time in days. The graph includes sample sizes and a p-value of 0.0002.*
FDA Label Image

Topiramate Tablets Usp (7ea951b6 B020 481f 8acc 12fb7a3a69fd 03)

Topiramate Tablets Usp (7ea951b6 B020 481f 8acc 12fb7a3a69fd 03)
Bar graph depicting the change from baseline to double-blind phase in average monthly migraine period rate with Topiramate treatment at varying doses (50 mg/day, 100 mg/day, 200 mg/day) compared to placebo. Results are shown for two studies (Study 11 and Study 12) with sample sizes indicated for each group, illustrating reductions in migraine periods with increasing doses of Topiramate.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Topiramate 25 mg film-coated tablets packaging label shows a quantity of 30 tablets. The label features the Remedy Repack Inc. logo and specifies the product is for prescription use only. Manufacturer information includes Zydus Pharm, Pennington, NJ. Storage instructions and repackaging details by RemedyRepack Inc., Indiana, PA, are also visible.*
FDA Label Image

Mm2 (Topiramate 25mg 70518 1718 01)

Mm2 (Topiramate 25mg 70518 1718 01)
Label for Topiramate 25 mg film-coated tablets, packaged quantity of 30 tablets. The label includes the proprietary name Topiramate, dosage strength 25 mg, and dosage form as tablets. The product is labeled as prescription only (RX ONLY) and repackaged by RemedyRepack Inc. The source manufacturer is Zydus Pharm, Pennington, NJ. The label also features storage instructions and a QR code.*
FDA Label Image

Mm3 (Topiramate 25mg 70518 1718 02)

Mm3 (Topiramate 25mg 70518 1718 02)
Topiramate 25 mg oral film-coated tablet in a single quantity packaging. The label shows the product name with strength, dosage form, and quantity. It is labeled Rx only and repackaged by RemedyRepack Inc. The manufacturer is Zydus Pharm, Pennington, NJ. Storage instructions and a QR code are also visible.*
FDA Label Image

Mm4 (Topiramate 25mg 70518 1718 03)

Mm4 (Topiramate 25mg 70518 1718 03)
Topiramate 25 mg film-coated tablets packaging label by RemedyRepack Inc. The label states a quantity of 90 tablets, with an oral route of administration. The label includes the NDC 70518-1718-03, manufacturing information from Zydus Pharm, and storage instructions. It also advises to see the package insert for directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.